AEYE Health 
Yes. Your staff capture 1 image per eye with the handheld camera during rooming. No eye specialist and no dilation are needed. The FDA-cleared autonomous AI delivers the diagnosis in about 1 minute.
AEYE-DS for primary care
Bring AI diabetic eye exams into primary care and close the care gap
Your staff captures 1 image per eye, without dilation, and FDA-cleared autonomous AI delivers an instant diabetic retinopathy diagnosis before the patient leaves. In 1 minute, close HEDIS EED care gaps and capture CPT 92229 revenue during routine visits.
FDA-Cleared
Autonomous AI
Why the diabetic eye exam is moving into
the primary care visit
More than 60% of diabetic patients never complete their recommended annual eye exam making diabetic retinopathy the leading cause of blindness among US adults. With AEYE-DS, your staff screen patients on the spot during routine visits and eliminate referral leakage.
1-minute diabetic retinopathy screening
1 image per eye, no dilation required. Capture to diagnosis in 1 minute.
Diagnosis by FDA-cleared autonomous AI
The AI diagnoses instantly, no specialist interpretation, so you discuss the result with the patient during the visit.
The only portable solution
AEYE-DS is the only FDA-cleared autonomous AI on a handheld camera. Screen in any exam room.
New revenue and quality credit in one visit
Point-of-care screening automatically triggers CPT 92229 reimbursement and closes the HEDIS EED gap before the patient leaves.
How the diabetic eye exam runs inside your existing workflow
The exam fits seamlessly into the workflow your staff already runs during rooming, before the provider enters, with no separate screening appointment.
-
Automated EHR screening alert
EHR flags due patient at check-in/rooming
-
Image capture
1 image per eye: no dilation, captured by your staff
-
Instant AI diagnosis
report generated and documented
-
Care gap closed & billing triggered
CPT 92229 billed, improved quality performance
Proven in primary care clinics
From 29% to 49% care gap closure in 4 months
UMass Memorial Health integrated AEYE-DS into routine primary care rooming, reducing screening time by 75% and nearly doubling annual diabetic eye exam adherence without disrupting clinic throughput.
Read the full case study"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."
"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."
"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."
One exam. Clinical, quality, and financial value.
Every completed diabetic eye exam earns twice, once in revenue and once in quality performance.
-
Reimbursable by primary care providers
CPT 92229 covers retinal imaging for diabetic retinopathy with point-of-care AI analysis and report, billed by the primary care provider. Because the AI reads autonomously, there is no reading fee to split.
-
Improves HEDIS scores and Star Ratings
The diabetic eye exam is documented and credited at the visit. Every closed gap counts HEDIS Eye Exam for Patients With Diabetes (EED) performance, which feeds Medicare AdvantageStar ratings and value-based performance.
-
Addresses point-of-care screening payment programs
Screening satisfies MIPS measure 117 in real time and may qualify PCPs for additional payer incentives.
FAQs
Turn every routine diabetic visit
into a completed eye exam
See how AEYE-DS fits your primary care workflow.